Status:
TERMINATED
Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)
Lead Sponsor:
Fundación Lindavista del Corazón AC
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Evaluate pleiotropic effects of simvastatin in hypertensive patients.
Eligibility Criteria
Inclusion
- Females Or Males Over 18 Years Old
- Patients With Systemic Arterial Hypertension Grade I And II According With The European Society Of Cardiology
- Left Ventricular hypertrophy Demonstrated By Echocardiography
- Mild To Moderated hypercholesterolemia
- Willing To Participate And Sign The Informed Consent Form (ICF)
Exclusion
- Type 1 Or 2 Diabetes Mellitus
- Familiar hypercholesterolemia
- Low Density Lipoprotein-Cholesterol (LDL-C) \> 190 mg/dl
- History Of Myocardial Infarction Or Stable Chronic Angina
- Triglycerides \>250 mg/dl
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00738972
Start Date
January 1 2008
End Date
August 1 2010
Last Update
August 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.